Don’t Call Her a Victim: After Surviving Opioids, Nan Goldin Goes After the Makers

Mclean Hospital

New York Times

Noted photographer and former patient at Fernside—one of McLean’s Signature Addiction Recovery Programs—calls out Oxycontin manufacture, Purdue Pharma, and the company owners and art patrons.

Read Full Article

Topics

Addiction Patient Experiences

McLean Main Navigation

In the Media: Don’t Call Her a Victim: After Surviving Opioids, Nan Goldin Goes After the Makers

New York Times

Does Marijuana Use Impact Driving When Sober?

2019: A Year of Achievement

Dr. Sophia Maurasse: 2019 National Compassionate Caregiver of the Year Award

Admission Process at McLean Hospital

In the Media: Don’t Call Her a Victim: After Surviving Opioids, Nan Goldin Goes After the Makers

New York Times

You May Also Like

Podcast: Let’s Talk About Steroids

Insights On Brain Health From The 2019 Forbes Healthcare Summit

Study Finds Increased Risk of Substance Use and Misuse Among Children of Marijuana Users

What It’s Like to Parent in Recovery

Resources

Latest Videos

Does Marijuana Use Impact Driving When Sober?

2019: A Year of Achievement

Dr. Sophia Maurasse: 2019 National Compassionate Caregiver of the Year Award

Admission Process at McLean Hospital

Keep Up With McLean!